GOG 0281
Trial Description:
A Randomized Phase II/III Study to Assess the Efficacy of Trametinib (GSK 1120212) in Patients With Recurrent or Progressive Low-Grade Serous Ovarian Cancer or Peritoneal Cancer
Lead Cooperative Group:
Participating Groups:
Trial Number:
Disease Site:
Ovarian
Trial Status:
Closed to Recruitment
Contact person:
dgershenson